← FDA Drug Approvals (Drugs@FDA)

ACITRETIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2024-08-05

Drug application

FDA Application #
ANDA217774
Application type
Abbreviated New Drug Application (Generic)
Brand name
ACITRETIN
Generic name
ACITRETIN
Active ingredients
ACITRETIN
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
ALEMBIC
Manufacturer
Alembic Pharmaceuticals Inc.
First approval
2024-08-05

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown